Skip navigation

The Next Frontier for A.I.? Drug Research

While in New York City, BERG CEO and President Niven Narain dropped into the Cheddar Network studios at the New York Stock Exchange to discuss how BERG uses patient biological data and artificial intelligence to develop hypotheses in the drug-development process.

Watch the interview: